BioClinica names David Peters new chief financial officer
BioClinica, a specialty clinical trials services and technology provider, has named David Peters executive vice president and chief financial officer.
Peters brings more than 25 years of financial and accounting experience with a focus in pharmaceutical services. Peters has directed all facets of accounting, financial functions and strategy in global businesses and has successfully negotiated more than 20 strategic partnership agreements. He was most recently chief financial officer at WCCT Global, where he developed a strategic plan to position the CRO for growth and investment. Previously, he was senior vice president of commercial and corporate development and chief financial officer of the late phase clinical group at inVentiv Health. Peters spent 15 years at Icon Clinical Research where he held the positions of senior vice president of global finance, vice president of finance North and South America, and controller.
Peters replaces executive vice president and chief financial officer Ted Kaminer, who is retiring after 12 years with the company.